About this trial
The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
5-year survivor of childhood cancer
Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)
Age at diagnosis <18 years
Age at study ≥16 years
Disqualifiers
Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)
<5 years after therapy of a relapse or palliative situation
Severe cognitive impairment, which makes it impossible to complete the questionnaire independently
Insufficient knowledge of the German language
Trial population
The study population consists of childhood cancer survivors, who were diagnosed in three Swiss pediatric oncology centers at age \<18 years and are ≥5-year from diagnosis and age ≥16 years at study inclusion. Additionally, survivors are at study start in follow-up care at one of the three pediatric oncology centers (group before transition) or have been transitioned to adult care not before 2014 (group after transition)
Trial design
Cohort
Prospective
Treatments tested in this trial
Transition model
Other interventionTransition of follow-up care of childhood cancer survivors to adult care
Treatment groups
Trial outcomes
Primary outcomes
Cancer Worry as part of transition readiness
Assessment via validated "Cancer Worry Scale"
Self-management as part of transition readiness
Assessment via validated "Self-Management Skill Scale"
Evaluation of needs for ongoing care as part of transition readiness
Assessment via validated "Scale for ongoing Care"
Evaluation of expectation for transition as part of transition readiness
Assessment via validated "Expectation Scale"
Secondary outcomes
Survivors' cancer specific knowledge
Assessment via questionnaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Kantonsspital Aarau
Lead sponsor
University Children's Hospital Basel
Collaborator
Luzerner Kantonsspital
Collaborator